Literature DB >> 10334754

Evidence based cardiology: prevention of congestive heart failure and management of asymptomatic left ventricular dysfunction.

R S McKelvie1, C R Benedict, S Yusuf.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10334754      PMCID： PMC1115781          DOI： 10.1136/bmj.318.7195.1400

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  28 in total

1.  Role of diabetes in congestive heart failure: the Framingham study.

Authors:  W B Kannel; M Hjortland; W P Castelli
Journal:  Am J Cardiol       Date:  1974-07       Impact factor: 2.778

2.  A comparison of the pathological spectrum of hypertensive, diabetic, and hypertensive-diabetic heart disease.

Authors:  K H van Hoeven; S M Factor
Journal:  Circulation       Date:  1990-09       Impact factor: 29.690

3.  Incidence of heart failure in eastern Finland: a population-based surveillance study.

Authors:  J Remes; A Reunanen; A Aromaa; K Pyörälä
Journal:  Eur Heart J       Date:  1992-05       Impact factor: 29.983

4.  Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD).

Authors:  G S Francis; C Benedict; D E Johnstone; P C Kirlin; J Nicklas; C S Liang; S H Kubo; E Rudin-Toretsky; S Yusuf
Journal:  Circulation       Date:  1990-11       Impact factor: 29.690

5.  Cardiac mechanics during development of heart failure. SOLVD Investigators.

Authors:  H Pouleur; M F Rousseau; C van Eyll; J Melin; M Youngblood; S Yusuf
Journal:  Circulation       Date:  1993-05       Impact factor: 29.690

6.  Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions.

Authors:  S Yusuf; C J Pepine; C Garces; H Pouleur; D Salem; J Kostis; C Benedict; M Rousseau; M Bourassa; B Pitt
Journal:  Lancet       Date:  1992-11-14       Impact factor: 79.321

Review 7.  The neurohumoral axis in congestive heart failure.

Authors:  G S Francis; S R Goldsmith; T B Levine; M T Olivari; J N Cohn
Journal:  Ann Intern Med       Date:  1984-09       Impact factor: 25.391

8.  Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions.

Authors:  S Yusuf; B Pitt; C E Davis; W B Hood; J N Cohn
Journal:  N Engl J Med       Date:  1992-09-03       Impact factor: 91.245

9.  Prognostic implications of subclinical left ventricular dilatation and systolic dysfunction in men free of overt cardiovascular disease (the Framingham Heart Study).

Authors:  M S Lauer; J C Evans; D Levy
Journal:  Am J Cardiol       Date:  1992-11-01       Impact factor: 2.778

10.  Atrial natriuretic factor in normal subjects and heart failure patients. Plasma levels and renal, hormonal, and hemodynamic responses to peptide infusion.

Authors:  R J Cody; S A Atlas; J H Laragh; S H Kubo; A B Covit; K S Ryman; A Shaknovich; K Pondolfino; M Clark; M J Camargo
Journal:  J Clin Invest       Date:  1986-11       Impact factor: 14.808
View more
  9 in total

1.  [Validity and usefulness of B-type natriuretic peptide (BNP) for early detection of left ventricular dysfunction in high-risk patients in primary care].

Authors:  José M Lobos Bejarano; Cristina Horrillo García; Ana I González-González; Angel Castellanos Rodríguez; Santiago Díaz Sánchez; Javier Castellanos Maroto; Ricardo Rodriguez-Barrientos; Miguel A García-Fernández
Journal:  Aten Primaria       Date:  2011-06-01       Impact factor: 1.137

Review 2.  Canadian Cardiovascular Society Consensus Conference recommendations on heart failure update 2007: Prevention, management during intercurrent illness or acute decompensation, and use of biomarkers.

Authors:  J Malcom O Arnold; Jonathan G Howlett; Paul Dorian; Anique Ducharme; Nadia Giannetti; Haissam Haddad; George A Heckman; Andrew Ignaszewski; Debra Isaac; Philip Jong; Peter Liu; Elizabeth Mann; Robert S McKelvie; Gordon W Moe; John D Parker; Anna M Svendsen; Ross T Tsuyuki; Kelly O'Halloran; Heather J Ross; Vivek Rao; Errol J Sequeira; Michel White
Journal:  Can J Cardiol       Date:  2007-01       Impact factor: 5.223

Review 3.  Should beta-blockers be used for the treatment of pediatric patients with chronic heart failure?

Authors:  Luke A Bruns; Charles E Canter
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

Review 4.  Heart failure.

Authors:  Robert Samuel McKelvie
Journal:  BMJ Clin Evid       Date:  2010-02-25

Review 5.  Heart failure.

Authors:  Robert Samuel McKelvie
Journal:  BMJ Clin Evid       Date:  2011-08-30

Review 6.  Prevention of heart failure.

Authors:  Tamara B Horwich; Gregg C Fonarow
Journal:  Curr Cardiol Rep       Date:  2002-05       Impact factor: 2.931

Review 7.  Do statins prevent heart failure in patients after myocardial infarction?

Authors:  Anique Ducharme; Jean Lucien Rouleau
Journal:  Curr Heart Fail Rep       Date:  2004-12

8.  Stage at diagnosis and survival among adolescents and young adults with lymphomas following the Affordable Care Act implementation in California.

Authors:  Renata Abrahão; Julianne J P Cooley; Frances B Maguire; Arti Parikh-Patel; Cyllene R Morris; Eleonor Bimla Schwarz; Ted Wun; Theresa H M Keegan
Journal:  Int J Cancer       Date:  2021-12-08       Impact factor: 7.396

9.  Positron emission tomography for the assessment of myocardial viability: an evidence-based analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2005-10-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.